SVB Leerink Maintains Market Perform on Pfizer, Lowers Price Target to $48

SVB Leerink analyst David Risinger maintains Pfizer (NYSE:PFE) with a Market Perform and lowers the price target from $49 to $48.

SVB Leerink analyst David Risinger maintains Pfizer (NYSE:PFE) with a Market Perform and lowers the price target from $49 to $48.

Total
0
Shares
Related Posts